| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/02/2009 | US20090170164 Recombinant protein production in a human cell |
| 07/02/2009 | US20090170163 Spacers to increase the expression of recombinant fusion proteins |
| 07/02/2009 | US20090170162 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc |
| 07/02/2009 | US20090170161 GDEP Enhancer Element and Use Thereof to Confer Retinal Specific Gene Expression |
| 07/02/2009 | US20090170160 Expression System |
| 07/02/2009 | US20090170159 Production of glycoproteins with reduced o-glycosylation |
| 07/02/2009 | US20090170158 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/02/2009 | US20090170157 Asparaginases |
| 07/02/2009 | US20090170156 Hydroxynitrile lyase |
| 07/02/2009 | US20090170155 Mutant Endoglycoceramidases With Enhanced Synthetic Activity |
| 07/02/2009 | US20090170154 modified so as to have, as a genomic DNA or plasmid DNA, a DNA molecule which includes a sigA gene or a gene functionally equivalent thereto; capable of enhancing productivity of proteins or polypeptides |
| 07/02/2009 | US20090170153 Effect of radiation on cellulase enzymes |
| 07/02/2009 | US20090170122 Human intestinal NPT2B |
| 07/02/2009 | US20090170098 Antibodies to cell-cycle regulatory protein p16, and uses related thereto |
| 07/02/2009 | US20090169579 Modified vaccinia Ankara virus avriant |
| 07/02/2009 | US20090169565 Neutrokine-alpha antibodies and methods of use thereof |
| 07/02/2009 | US20090169564 Stimulus Inducible Protein Kinase Complex and Methods of Use Therefor |
| 07/02/2009 | US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
| 07/02/2009 | US20090169562 Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169553 Novel Protein Fusion/Tag Technology |
| 07/02/2009 | US20090169548 Binding molecules |
| 07/02/2009 | US20090169536 Polypeptide Having Phytase Activity and Nucleotide Sequence Encoding the Same |
| 07/02/2009 | US20090169534 Variant Forms of Urate Oxidase and Use Thereof |
| 07/02/2009 | US20090169527 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 07/02/2009 | US20090169513 Expression of virus entry inhibitors and recombinant AAV therefor |
| 07/02/2009 | US20090169509 O-linked glycosylation of peptides |
| 07/02/2009 | US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 07/02/2009 | CA2709645A1 Sm-protein based secretion engineering |
| 07/02/2009 | CA2709500A1 Type iii secretion system component protein pa1698 of pseudomonas aeruginosa |
| 07/02/2009 | CA2708740A1 Hepatitis c virus antibodies |
| 07/02/2009 | CA2708407A1 Humanized anti-human cd34 antibody, the preparation method and uses thereof |
| 07/01/2009 | EP2075336A1 Purification of recombinant proteins fused to multiple epitopes |
| 07/01/2009 | EP2075335A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075257A1 Preparation of antibody using mrl/lpr mouse |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2074148A1 Novel antiproliferation antibodies |
| 07/01/2009 | EP1677665A4 Determination of ions using ion-sensitive enzymes |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1359883A4 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1261704B1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP1111059B1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | CN101469338A Enzymolysis preparation of Cordyce militaris polypeptide and product |
| 07/01/2009 | CN101469329A Compositions and methods for increasing bone mineralization |
| 07/01/2009 | CN100506999C Optimized expression of HPV 31 L1 in yeast |
| 07/01/2009 | CN100506992C Recombinant endothelial chalone high expression technology in bacillus coli |
| 07/01/2009 | CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 06/30/2009 | US7553956 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages |
| 06/30/2009 | US7553937 Specific antibodies for diagnosing heart failure |
| 06/30/2009 | US7553931 Convertase for use in identifying modulator for treatment and prevention of arthritis, kidney, inflammatory, heart and nervous system disorders |
| 06/30/2009 | US7553655 Transgenic cells for use as bioreactors in expression of amidated peptides |
| 06/30/2009 | US7553650 Polynucleotide encoding a mutant transglutaminase |
| 06/30/2009 | US7553648 Cytochrome P450 monooxygenases consisting of thermophilic bacteria |
| 06/30/2009 | US7553642 Capable of sodium-independently transporting branched amino acids |
| 06/30/2009 | US7553639 Alpha-synuclein kinase |
| 06/30/2009 | US7553637 Using expression vector comprising nucleotide sequences coding membrane insertion protein as tool in improving exogenous gene expression in host cells |
| 06/30/2009 | US7553636 Plasmid comprising nucleotide sequences coding poly- gamma -glutamate synthetase for use in developing vaccine for prevention and treatment of bacillus infection |
| 06/30/2009 | US7553634 Lysis, fermentation, diafiltration |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553486 Anti-VEGF treatment for radiation-induced vasculopathy |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2395343C Use of acid-stable proteases in animal feed |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2259421C Labelling and selection of molecules |
| 06/30/2009 | CA2240149C Improved neurospora hosts for the production of recombinant proteins, and methods for producing the same |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2135208C Immunoglobulin binding proteins derived from l protein and their uses |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009079618A1 Enzyme engineering systems and methods |
| 06/25/2009 | WO2009079489A1 Methods for screening of opioid receptor neutral antagonists and inverse agonists and uses thereof |
| 06/25/2009 | WO2009076711A1 Enzymes and methods for degrading chlorinated s-triazines |
| 06/25/2009 | WO2009026393A3 Amino acid substituted molecules |
| 06/25/2009 | US20090165154 Genetically engineered ungulates for use as bioreactors for human antibodies; reducing transmission of spongiform encephalopy |
| 06/25/2009 | US20090163592 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/25/2009 | US20090163438 Gankyrin |
| 06/25/2009 | US20090163397 Novel CBH1 Homologs And Variant CBH1 Cellulases |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162902 Monoclonal antibody that binds protein A from Staphylococcus aureus; use in diagnosis, therapy and detection |
| 06/25/2009 | US20090162901 Inducible Eukaryotic Expression System |
| 06/25/2009 | US20090162900 Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such of such products |
| 06/25/2009 | US20090162899 Mannitol induced promoter systems in bacterial host cells |
| 06/25/2009 | US20090162898 High copy number self-replicating plasmids in pseudomonas |
| 06/25/2009 | US20090162897 Promoter Sequences |
| 06/25/2009 | US20090162896 Production of Recombinant Collagen Like Proteins |
| 06/25/2009 | US20090162895 fixing carbon; for transforming and propagating plants and/or photosynthetic organisms so as to improve yields of preferential foodstuffs, enhance biomass energy and increase nutrient concentration |
| 06/25/2009 | US20090162894 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide |